RWAY presents a detailed schedule of control and non-control investments across sectors such as health care equipment and services, pharmaceuticals and biotechnology, application software, technology hardware, financial services, consumer staples distribution and retail, commercial and professional services, media and entertainment, and insurance.
The portfolio includes many senior secured debt positions that reference SOFR or Prime plus a spread, with contractual rate floors and features such as PIK and ETP components; examples include loans to 4Web, Inc. at SOFR+9.25% with a 12.75% floor and 34.43% ETP, Biotricity, Inc. at SOFR+10.50% with an 11.50% floor and 10.29% ETP, and SPB C‑2024, LLC in Multi-Sector Holdings at fixed 15.00% PIK with 1.57% ETP. Alongside debt, RWAY holds numerous warrants, preferred and common equity stakes, and contractual rights such as success fees, royalties, contingent value rights, and earnouts, each with stated initial acquisition and maturity dates, with some instruments maturing as far out as 2035 and 2039.
Runway Growth Finance Corp. reported second-quarter 2026 total investment income of $37.0 million and net investment income of $18.2 million, or $0.43 per share, compared to $35.1 million and $13.9 million a year earlier. The investment portfolio reached $1.2 billion at fair value across 79 companies, with a dollar-weighted annualized yield on debt investments of 14.2%.
Net realized loss was $45.3 million, offset by $54.3 million of net unrealized gain, producing a $27.2 million net increase in net assets from operations, or $0.65 per share. Net asset value per share was $11.91 and total net assets were $502.6 million, up from $438.2 million on March 31, 2026. The company funded $239.6 million of investments tied to the SWK Holdings acquisition plus $85.8 million in other fundings, received $36.5 million of repayments and sale proceeds, and repurchased 249,169 shares for $1.4 million. Liquidity totaled $210.8 million with a core leverage ratio of about 136%. The board declared a $0.33 per share third-quarter 2026 dividend, reduced total credit facility commitments to $425.0 million after quarter-end, and appointed Michael Rovner as Co‑Chief Executive Officer alongside R. David Spreng.
Runway Growth Finance Corp. declared a third quarter 2026 regular cash dividend of $0.33 per share. The Board of Directors approved the distribution on August 5, 2026 for stockholders of record as of the close of business on August 17, 2026.
The dividend is scheduled to be paid on or about August 31, 2026. The company states that it generally intends to distribute substantially all of its available earnings on a quarterly basis, subject to Board discretion and regulatory requirements, and maintains an opt-out dividend reinvestment plan under which non-opting stockholders have dividends automatically reinvested in additional common shares.
Runway Growth Finance Corp. entered into its eighth amendment to an amended and restated credit agreement among the company as borrower, financial institutions as lenders, and KeyBank National Association as administrative agent, effective as of June 30, 2026. The amendment was executed on July 13, 2026.
The Credit Facility Amendment reduces the company’s credit facility commitment from $550,000,000 to $425,000,000, permits future prepayment and termination of a specified lender’s commitments on a non-pro rata basis, revises certain financial covenants, updates key person trigger events, and adjusts loan eligibility criteria and borrowing base concentration limits.
Runway Growth Finance Corp. provided a second‑quarter 2026 business and portfolio update and outlined a capital allocation plan focused on share purchases while its stock trades well below net asset value (NAV). The company’s investment adviser, affiliates, board and management intend to acquire up to 10% of outstanding common stock over the next 24 months, as long as shares trade at or below 70% of NAV, which the company states implies a price of $8.49 based on March 31, 2026 NAV per share. This initiative complements an existing $15.0 million stock repurchase program running from May 7, 2026 through May 7, 2027 and an intention to prioritize repurchases when the stock trades at a significant discount.
For the quarter ended June 30, 2026, Runway Growth funded $85.8 million of new and existing investments, excluding the SWK Holdings transaction, and completed several new and follow‑on loans and a restructuring. Following the April 6, 2026 acquisition of SWK Holdings, it funded approximately $239.6 million of investments acquired in that deal. Portfolio liquidity events totaled $36.5 million, including partial principal repayments, scheduled amortization and $10.1 million of equity sale proceeds from Eton Pharmaceuticals, Inc. As of June 30, 2026, the portfolio comprised 59 debt investments across 46 companies and 102 equity investments across 67 companies in technology, healthcare and select consumer sectors.
Runway Growth Finance Corp. executive Carmela Thomson filed an initial ownership report showing her direct holdings in the company. As CFO, Treasurer and Secretary, she reports beneficial ownership of 4,840 shares of Common Stock, par value $0.01 per share. This Form 3 does not reflect any recent buy or sell transactions, only her existing equity position.
Runway Growth Finance Corp. reported results of its 2026 Annual Meeting of Stockholders held on June 23, 2026. Stockholders re-elected Alexander Duka and Gary Kovacs as Class I directors to serve until the 2029 annual meeting.
Approximately 42.5 million shares were outstanding and entitled to vote as of the April 24, 2026 record date. Duka received 16,142,431 votes for and 8,625,120 withheld, while Kovacs received 15,965,968 for and 8,801,583 withheld, with 7,750,344 broker non-votes for each. Stockholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026, with 25,348,416 votes for, 6,981,350 against and 188,129 abstentions.
Runway Growth Finance Corp. entered into an underwriting agreement and issued and sold $50,000,000 aggregate principal amount of its 7.00% Notes due 2029. The Notes pay 7.00% interest semi-annually on June 1 and December 1, starting December 1, 2026, and mature on December 1, 2029.
The Notes are unsecured senior obligations ranking pari passu with the company’s other unsecured, unsubordinated debt, and are effectively and structurally subordinated to certain other obligations. They may be redeemed before and after June 1, 2029 under specified call prices, and include a change of control repurchase right at 100% of principal plus accrued interest.
The Notes were issued under a registered offering using the company’s Form N‑2 shelf, with the transaction closing on May 29, 2026. Runway Growth Finance intends to use the net proceeds to repay borrowings under its Credit Facility and for other general corporate purposes.
Runway Growth Finance Corp. Chief Financial and Operating Officer Thomas B. Raterman reported open‑market purchases of company stock. He bought a total of 10,000 shares of common stock in three non-derivative transactions at prices between $6.335 and $6.67 per share, bringing his direct holdings to 98,359 shares. This amended Form 4 corrects earlier filings that had mistakenly reported these transactions using code "A" and now properly classifies them as code "P" open‑market purchases.
Runway Growth Finance Corp. President and CEO R. David Spreng reported an open-market purchase of 3,000 shares of common stock on May 20, 2026 at $6.365 per share. Following this trade, he directly holds 193,504 common shares and indirectly holds 41,371 shares through a 401(k) plan.
This Form 4/A is an amendment that corrects the original transaction code, changing it from an award entry to a purchase (code "P") for the same transaction date and amount.